Kosmeri, C.; Baltogianni, M.; Giapros, V.; Siomou, E.; Tsinopoulou, V.-R.; Balomenou, F.; Serbis, A.
Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients. Endocrines 2024, 5, 214-224.
https://doi.org/10.3390/endocrines5020015
AMA Style
Kosmeri C, Baltogianni M, Giapros V, Siomou E, Tsinopoulou V-R, Balomenou F, Serbis A.
Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients. Endocrines. 2024; 5(2):214-224.
https://doi.org/10.3390/endocrines5020015
Chicago/Turabian Style
Kosmeri, Chrysoula, Maria Baltogianni, Vasileios Giapros, Ekaterini Siomou, Vasiliki-Regina Tsinopoulou, Foteini Balomenou, and Anastasios Serbis.
2024. "Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients" Endocrines 5, no. 2: 214-224.
https://doi.org/10.3390/endocrines5020015
APA Style
Kosmeri, C., Baltogianni, M., Giapros, V., Siomou, E., Tsinopoulou, V.-R., Balomenou, F., & Serbis, A.
(2024). Which Diabetes Patients Will Benefit the Most from Once-Weekly Basal Insulin Analogs? A Review with a Special Focus on Type 1 Diabetes Patients. Endocrines, 5(2), 214-224.
https://doi.org/10.3390/endocrines5020015
